Chronic obstructive pulmonary disease (COPD)
Advanced Cardiopulmonary Dynamics
Dr. Forrest M. Bird President Bush Award President Obama Award
Main About Us Products Contacts Distributors Educational Pages News/Articles Seminars
Additional Information for:
Patients
Physicians
Insurance Providers
 
HC Impulsator

HC Impulsator® is available to Limited Release only in the U.S.
Click to view the training video

Home Care Services
(Patient Support)

Valarie Zimmerman:
208- 263-2549 Ext 161
Email: homecare@percussionaire.com

 
 
AARC Discussion group on VDR
Click to View>>
 
News Breaks
Nightline Video shows IPV-1C® being used to treat H1N1 patients
In the first section you can see an IPV-1C® by the patient and in the second the patient is being given a treatment.
Click here to see the segment>>

Concerns continue over H1N1
To hear Respiratory Care & Sleep Medicine's H1N1 Flu Roundtable
Click here >>

H1N1: IPV improves on HFOV in Central Illinois Hospital< <click here > >


World Expert on Ventilators Collaborates With Upstate Researchers!!
click here to view the whole story!

IPV Related Studies
To view articles and studies involving IPV
click here

Bookmark and Share
Dr. Forrest M. Bird Speaking at the SCCM Lecture
Click on the MP3 player below to listen.
 

Physiological response to intrapulmonary percussive ventilation in stable COPD patients.

PERCUSSIONAIRE® CORPORATION IPV ® Technology



COPD and Percussionaire treatment

Physiological response to intrapulmonary percussive ventilation in stable COPD patients.

Stefano Nava,1, Nicola Barbarito, Giancarlo Piaggi, Elisa De Mattia1, Serena Cirio Respiratory Medicine (2006) 100, 1526–1533

Objective: to assess the physiological response to IPV, on patients’ breathing pattern, inspiratory effort, lung mechanics and tolerance to ventilation.

Design: randomized trials using IPV through a face mask at different pressure/frequency combinations (1.2 bar/250 cycles/min; 1.8/250;1.2/350; 1.8/350)

Patients: Ten COPD patients.

Conclusions: -IPV was able to guarantee an adequate ventilation, while inducing a significant unloading of the diaphragm during the ‘‘low-frequency’’ trials. -Tolerance to ventilation and oxygen saturation were satisfactory and did not change during the different trials.


Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial.

Frédéric Vargas, Hoang Nam Bui, Alexandre Boyer, Louis Rachid Salmi, Georges Gbikpi-Benissan, Hervé Guenard, Didier Gruson1 and Gilles Hilbert. Critical Care 2005,Vol 9 No 4

Design: randomized trial, standard treatment (control group) vs standard treatment plus IPV (IPV group)

Patients: Thirty-three patients with exacerbations of COPD.

Results: -Thirty minutes of IPV led to a significant decrease in respiratory rate, an increase in PaO2 and a decrease in PaCO2 (p < 0.05). -Exacerbation worsened in 6 out of 17 patients in the control group versus 0 out of 16 in the IPV group (p < 0.05). -The hospital stay was significantly shorter in the IPV group than in the control group (6.8 ± 1.0 vs. 7.9 ± 1.3 days, p < 0.05).


 

What is COPD?

Chronic obstructive pulmonary disease (COPD) refers to chronic bronchitis and emphysema, a pair of two commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs causing shortness of breath.

 
COPD Video for understanding
COPD definitions
Living with COPD
COPD Foundation
COPD
PERCUSSIONAIRE® CORPORATION


P.O. Box 817 Sandpoint, Idaho 83864 U.S.A.
Phone (208) 263-2549  Fax (208) 263-0577